Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;22(1):899.
doi: 10.1186/s12879-022-07895-1.

Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27-CD38+IFN-γ+CD4+ T cells for discrimination of active tuberculosis

Affiliations

Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27-CD38+IFN-γ+CD4+ T cells for discrimination of active tuberculosis

Yong Fang et al. BMC Infect Dis. .

Abstract

Background: Active tuberculosis (ATB) originates from primary Mycobacterium tuberculosis (MTB) infection or reactivation of latent tuberculosis. Besides bacteriological examination, MTB-reactive immunocytes detection can be an alternative testing for discrimination of active tuberculosis. The purpose of this study is to investigate the accuracy of peripheral blood CD27-CD38+IFN-γ+CD4+T cells in ATB diagnosis.

Methods: This prospective diagnostic accuracy study was conducted at Shanghai Pulmonary Hospital between January 2019 and December 2021. Patients with ATB, non-tuberculosis mycobacterium infection (NTM), latent tuberculosis infection (LTBI), other respiratory diseases (OD), and healthy individuals (HC) were enrolled. The accuracy of CD27-CD38+IFN-γ+CD4+/CD4+ and other phenotypic markers for ATB diagnosis was assessed.

Results: A total of 376 patients (237 ATB, 38 LTBI, 8 NTM, 50 OD, and 43 HC) were enrolled. The ratios of CD4+IFN-γ+CD27- and CD4+IFN-γ+CD27-CD38+ profiles in CD4+IFN-γ+ cells and the ratios of CD4+IFN-γ+CD38+, CD4+IFN-γ+CD27-, and CD4+IFN-γ+CD38+CD27- profiles in CD4+ cells in the ATB group were significantly higher than in the other groups. The area under the curve (AUC) of CD27-CD38+IFN-γ+CD4+/CD4+ for the diagnosis of ATB was the highest, with a value of 0.890. With the optimal cutoff value of 1.34 × 10-4, the sensitivity and specificity of CD27-CD38+IFN-γ+CD4+/CD4+ for ATB diagnosis was 0.869 and 0.849, respectively.

Conclusion: CD27-CD38+IFN-γ+CD4+/CD4+ might be a potential biomarker for active tuberculosis diagnosis.

Keywords: Biomarker; CD27; CD38; Diagnosis; Flow cytometry; IFN−γ; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Participant enrollment flowchart. TB tuberculosis, ATB active tuberculosis, LTBI latent tuberculosis infection, NTM non-tuberculous mycobacterium pulmonary disease, OD other respiratory diseases, HC healthy control, PTB pulmonary tuberculosis, EPTB extra-pulmonary tuberculosis, IGRA interferon-γ release assay
Fig. 2
Fig. 2
Flow cytometry gating strategy for CD4+IFN-γ+CD38+CD27 T cells from the peripheral blood lymphocyte of the participants. A Peripheral blood lymphocyte without stimulation by ESAT-6/CFP-10 peptides (negative control) and with 16-h stimulation by ESAT-6/CFP-10 peptides (E6C10). B The comparison of CD27 or CD38 expression in ESAT-6/CFP-10 peptides stimulated CD4+IFN-γ+ T cells to the unstimulated cells
Fig. 3
Fig. 3
The frequency of CD27 and CD38-expressing populations in CD4+ IFN-γ+ T cells and in CD4+ T cells for the various groups. A CD4+IFN-γ+CD27+ and CD4+IFNγ+CD27, B CD4+IFNγ+CD38+ and CD4+IFN-γ+CD38, C CD4+IFNγ+CD38+CD27 and CD4+IFN-γ+CD27+CD38, D CD4+IFNγ+CD27, E CD4+IFNγ+CD38+, and F CD4+IFNγ+CD38+CD27 in CD4+ IFN-γ+ T cell in peripheral blood stimulated with ESAT 6/CFP10 were compared in ATB and other groups. The phenotypic markers G CD4+IFNγ+CD27, H CD4+IFNγ+CD38+, and I CD4+IFNγ+CD38+CD27 on CD4+ T cell in peripheral blood stimulated with ESAT 6/CFP10 in each group was compared. ATB active tuberculosis, LTBI latent tuberculosis infection, NTM non-tuberculous mycobacterium pulmonary disease, OD other respiratory diseases, HC healthy control
Fig. 4
Fig. 4
Receiver operating characteristics (ROC) curves and accuracy for the diagnosis of active tuberculosis (ATB). A ROC curves of different indicators for the diagnosis of ATB. B Sensitivity and specificity corresponding to the cutoff values. The dotted line indicates 80% sensitivity and 80% specificity. C The dotted line represents the cutoff value of CD4+IFN-γ+CD38+CD27/CD4+ as 1.34 × 10–4. ATB active tuberculosis, LTBI latent tuberculosis infection, NTM non-tuberculous mycobacterium pulmonary disease, OD other respiratory diseases, HC healthy control
Fig. 5
Fig. 5
The phenotypic marker CD4+IFNγ+CD38+CD27 on CD4+ cells in different subgroups. A The phenotypic marker CD4+IFN-γ+CD38+CD27 on CD4+ cells with negative TB culture stimulated with ESAT 6/CFP10. B The phenotypic marker CD4+IFN-γ+CD38+CD27 on CD4+ cells with EPTB stimulated with ESAT 6/CFP10. C+: TB culture+; C: TB culture; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis; LTBI: latent tuberculosis infection; NTM: non-tuberculous mycobacterium pulmonary disease; OD: other respiratory diseases; HC: healthy control

Similar articles

Cited by

References

    1. GBDT Collaborators The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18(3):261–284. doi: 10.1016/S1473-3099(17)30703-X. - DOI - PMC - PubMed
    1. Grobusch MP, Kapata N. Global burden of tuberculosis: where we are and what to do. Lancet Infect Dis. 2018;18(12):1291–1293. doi: 10.1016/S1473-3099(18)30654-6. - DOI - PubMed
    1. World Health Organization. Global tuberculosis report 2018. World Health Organization. WHO/CDS/TB; 2018.
    1. Zhu S, et al. The burden and challenges of tuberculosis in China: findings from the global burden of disease study 2015. Sci Rep. 2017;7(1):14601. doi: 10.1038/s41598-017-15024-1. - DOI - PMC - PubMed
    1. Cui X, Gao L, Cao B. Management of latent tuberculosis infection in China: exploring solutions suitable for high-burden countries. Int J Infect Dis. 2020;92S:S37–S40. doi: 10.1016/j.ijid.2020.02.034. - DOI - PubMed

Substances